DK504889A - N-heterocykliske forbindelser - Google Patents

N-heterocykliske forbindelser

Info

Publication number
DK504889A
DK504889A DK504889A DK504889A DK504889A DK 504889 A DK504889 A DK 504889A DK 504889 A DK504889 A DK 504889A DK 504889 A DK504889 A DK 504889A DK 504889 A DK504889 A DK 504889A
Authority
DK
Denmark
Prior art keywords
sulphur
nitrogen
chem
oxygen
group
Prior art date
Application number
DK504889A
Other languages
Danish (da)
English (en)
Other versions
DK504889D0 (da
Inventor
Barry Sidney Orlek
Richard Eric Faulkner
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888824071A external-priority patent/GB8824071D0/en
Priority claimed from GB888830223A external-priority patent/GB8830223D0/en
Priority claimed from GB898920660A external-priority patent/GB8920660D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of DK504889D0 publication Critical patent/DK504889D0/da
Publication of DK504889A publication Critical patent/DK504889A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK504889A 1988-10-13 1989-10-11 N-heterocykliske forbindelser DK504889A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888824071A GB8824071D0 (en) 1988-10-13 1988-10-13 Novel compounds
GB888830223A GB8830223D0 (en) 1988-12-23 1988-12-23 Novel compounds
GB898920660A GB8920660D0 (en) 1989-09-18 1989-09-18 Novel compounds

Publications (2)

Publication Number Publication Date
DK504889D0 DK504889D0 (da) 1989-10-11
DK504889A true DK504889A (da) 1990-04-14

Family

ID=27264121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK504889A DK504889A (da) 1988-10-13 1989-10-11 N-heterocykliske forbindelser

Country Status (9)

Country Link
US (1) US5166357A (de)
EP (1) EP0366304B1 (de)
JP (1) JP2934743B2 (de)
AT (1) ATE165095T1 (de)
AU (1) AU4278289A (de)
CA (1) CA2000041A1 (de)
DE (1) DE68928644T2 (de)
DK (1) DK504889A (de)
PT (1) PT91956B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227684A (en) * 1988-01-30 1991-07-26 Merck Sharp & Dohme Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions
EP0402056A3 (de) * 1989-06-06 1991-09-04 Beecham Group p.l.c. Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE69030695T2 (de) * 1989-08-16 1998-01-08 Beecham Group Plc Azabicyclische Verbindungen
EP0427390B1 (de) * 1989-10-07 1996-03-27 Beecham Group Plc Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0563036A1 (de) * 1990-12-21 1993-10-06 Merck Sharp & Dohme Ltd. 4-azatricyclo[2.2.1.0 2,6]heptanderivate und arzneimittel
WO1997011073A1 (en) * 1995-09-22 1997-03-27 Novo Nordisk A/S Novel substituted azacyclic or azabicyclic compounds
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
CA2362124A1 (en) * 1999-03-30 2000-10-05 Randal King Process for the preparation of .alpha.-methylenelactones and .alpha.-substituted hydrocarbylidene lactones
CA2361037A1 (en) * 1999-03-30 2000-10-05 Leo E. Manzer Process for the preparation of .alpha.-methylene lactones
US6362346B1 (en) 1999-11-12 2002-03-26 E. I. Du Pont De Nemours And Company Process for the preparation of α-methylene-γ-butyrolactone and α-acetoxymethyl-γ-butyrolactone
US6642346B2 (en) 2000-02-28 2003-11-04 E. I. Du Pont De Nemours And Company Coating compositions containing substituted and unsubstituted exomethylene lactone or lactam monomers
US6531616B2 (en) 2000-12-22 2003-03-11 E. I. Du Pont De Nemours And Company Process for the preparation of a-methylenelactones and a-substituted hydrocarbylidene lactones
KR100428408B1 (ko) * 2001-12-14 2004-04-28 학교법인 성균관대학 α-메틸렌-γ-부티로락톤의 제조방법
DE60301127T2 (de) 2002-01-07 2006-04-20 E.I. Du Pont De Nemours And Co., Wilmington Methylenlacton synthese in superkritischen flüssigkeiten
US7314942B2 (en) 2002-01-07 2008-01-01 E. I. Dupont De Nemours & Co. Methylenelactones syntheses in supercritical fluids
JP2009506069A (ja) * 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
CN102276559B (zh) * 2011-08-12 2014-05-28 河北威远生化农药有限公司 3-羟甲基四氢呋喃的合成方法
WO2023151894A1 (en) 2022-02-11 2023-08-17 Henkel Ag & Co. Kgaa Process for the synthesis of alpha-methylene-gamma-butyrolactone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8615785D0 (en) * 1986-06-27 1986-08-06 Beecham Group Plc Compounds
EP0261763B1 (de) * 1986-06-27 1994-02-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen
ATE133415T1 (de) * 1987-04-15 1996-02-15 Beecham Group Plc Am brückenkopf substituierte azabicyclenderivate
EP0307141B1 (de) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazole und Thiazole zur Behandlung seniler Demenz
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
EP0322182A3 (de) * 1987-12-22 1992-01-02 Beecham Group Plc Azabicyclische-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
JP2934743B2 (ja) 1999-08-16
DK504889D0 (da) 1989-10-11
CA2000041A1 (en) 1990-04-13
ATE165095T1 (de) 1998-05-15
AU4278289A (en) 1990-04-26
EP0366304B1 (de) 1998-04-15
PT91956B (pt) 1995-05-31
US5166357A (en) 1992-11-24
PT91956A (pt) 1990-04-30
EP0366304A3 (de) 1991-09-11
DE68928644D1 (de) 1998-05-20
EP0366304A2 (de) 1990-05-02
DE68928644T2 (de) 1998-08-27
JPH02134380A (ja) 1990-05-23

Similar Documents

Publication Publication Date Title
DK504889A (da) N-heterocykliske forbindelser
DE3854932T2 (de) Am Brückenkopf substituierte Azabicyclenderivate
NO951813L (no) Bicyklisk heterocyklisk sulfonamid og sulfonester-derivater
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
DK584886D0 (da) Vanduoplaeselige, mono- og disubstituerede derivater af rapamycin og farmaceutisk acceptable salte deraf
BE1003256A5 (fr) Derives de la butynylamine.
ES2013035A6 (es) Un metodo para preparar derivados de acilfenol.
ES2043834T3 (es) Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.
GB8917957D0 (en) Novel compounds
ATE174593T1 (de) Neue bisoxadiazolidinderivate
AU639493B2 (en) Azabicyclo compounds
ATE302199T1 (de) Quinalozinon-derivate
DK0434440T3 (da) Benzoxazinderivater, benzothiazinderivater og herbicider omfattende disse
ATE153024T1 (de) Azabicyclische verbindungen
DE69708198D1 (de) Muscarinische Rezeptor-Agonisten
DE69418641D1 (de) Molluskizide

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment